ChartRow logo
Share this page
ABBV
$285.42+0.71%
as of close, Oct 16, 2026
☾ AH $285.42 +0.71%
PeersMRNALLYMDTUNHJNJTMO

ABBV financial statements

The full income statement, balance sheet, and cash-flow statement for AbbVie Inc. (ABBV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 1.77B2024-09 1.77B2024-12 1.77B2025-03 1.77B2025-06 1.77B2025-09 1.77B2025-12 1.77B2026-03 1.77B2026-06 1.77B+0.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue61.2B+8.6%56.3B+3.7%54.3B-6.4%58.1B+3.3%56.2B+22.7%
Cost of revenue18.2B+7.7%16.9B-17.2%20.4B+17.2%17.4B-0.2%17.4B+13.4%
Research & development9.10B-28.9%12.8B+66.7%7.67B+17.9%6.51B-6.0%6.92B+8.5%
Selling, general & administrative14.0B-5.0%14.8B+14.6%12.9B-15.6%15.3B+23.6%12.3B+9.3%
Amortization of intangibles7.38B-3.2%7.62B-4.1%7.95B+3.3%7.69B-0.4%7.72B+33.0%
Operating income15.1B+65.0%9.14B-28.4%12.8B-29.6%18.1B+1.1%17.9B+57.7%
Interest expense2.89B+3.0%2.81B+26.3%2.22B-0.3%2.23B-8.0%2.42B-1.3%
Other non-operating income-5.79B-78.8%-3.24B+30.7%-4.68B-91.1%-2.45B+2.1%-2.50B+55.5%
Pre-tax income6.60B+77.5%3.72B-40.5%6.25B-53.6%13.5B+3.8%13.0B+282.3%
Income tax2.36B+514.7%-570M-141.4%1.38B-15.6%1.63B+13.3%1.44B+217.6%
4.23B-1.2%4.28B-12.0%4.86B-58.9%11.8B+2.5%11.5B+150.0%
Net income to non-controlling interest7.00M-12.5%8.00M-20.0%10.0M+11.1%9.00M+28.6%7.00M+16.7%
Net income to common4.19B-1.2%4.24B-12.1%4.82B-59.1%11.8B+2.7%11.5B+151.7%
$2.36-1.3%$2.39-12.1%$2.72-59.0%$6.63+2.8%$6.45+137.1%
EPS (basic)$2.37-1.2%$2.40-12.1%$2.73-58.9%$6.65+2.6%$6.48+137.4%
Weighted-avg shares (basic)1.77B+0.0%1.77B+0.1%1.77B-0.2%1.77B+0.1%1.77B+6.2%
Weighted-avg shares (diluted)1.77B+0.0%1.77B+0.0%1.77B-0.3%1.78B+0.1%1.78B+6.2%
Dividends per share$6.65+5.7%$6.29+5.0%$5.99+4.9%$5.71+7.5%$5.31+9.7%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
29.1B+13.6%25.6B-22.5%33.0B+15.9%28.5B+1.9%27.9B+15.5%
Cash & equivalents5.23B-5.3%5.52B-56.9%12.8B+39.3%9.20B-5.6%9.75B+15.4%
Short-term investments28.0M-9.7%31.0M+1450.0%2.00M-92.9%28.0M-66.7%84.0M+180.0%
Accounts receivable12.6B+15.3%10.9B-2.1%11.2B-0.9%11.3B+12.8%9.98B+13.1%
Inventory4.95B+18.4%4.18B+2.0%4.10B+14.5%3.58B+14.4%3.13B-5.5%
Prepaid expenses
6.29B————
134B-0.9%135B+0.3%135B-2.9%139B-5.3%147B-2.7%
Property, plant & equipment5.63B+9.6%5.13B+2.9%4.99B+1.1%4.93B-3.4%5.11B-2.6%
Operating lease right-of-use737M+1.9%723M-2.8%744M+0.9%737M-3.3%762M-14.9%
Goodwill35.6B+2.0%35.0B+8.2%32.3B+0.4%32.2B-0.7%32.4B-2.2%
Intangible assets52.6B-12.4%60.1B+8.0%55.6B-17.5%67.4B-11.2%76.0B-8.4%
Long-term investments268M-3.9%279M-8.2%304M+26.1%241M-13.0%277M-5.5%
Other non-current assets10.7B+17.3%9.14B+7.4%8.51B+52.8%5.57B+14.1%4.88B+0.7%
43.3B+11.7%38.7B+2.4%37.8B+28.1%29.5B-16.1%35.2B+22.8%
Accounts payable3.59B+22.0%2.94B-20.1%3.69B+25.7%2.93B+1.8%2.88B+26.6%
Accrued liabilities34.7B+8.7%31.9B+4.2%30.6B+20.7%25.4B+11.9%22.7B+12.6%
Short-term & current debt2.50B0.000.00-100.0%1.00M-92.9%14.0M-58.8%
Current lease liability194M+9.0%178M+7.2%166M+0.0%166M-6.7%178M+1.7%
Finance lease liability (current)19.0M+11.8%17.0M+13.3%15.0M-11.8%17.0M+88.9%9.00M+12.5%
Long-term debt64.5B-3.5%66.8B+12.8%59.2B-6.2%63.1B-16.9%76.0B-10.6%
Non-current lease liability689M-1.1%697M-5.2%735M-2.5%754M+5.8%713M-14.3%
Operating lease liability (total)883M+0.9%875M-2.9%901M-2.1%920M+3.3%891M-11.5%
Finance lease liability (total)41.0M+2.5%40.0M-4.8%42.0M+23.5%34.0M+0.0%34.0M+17.2%
Finance lease liability22.0M-4.3%23.0M-14.8%27.0M+58.8%17.0M-32.0%25.0M+19.0%
Deferred tax liabilities2.39B-7.4%2.58B+32.1%1.95B-10.9%2.19B-27.2%3.01B-17.5%
Other non-current liabilities32.6B+8.1%30.1B-6.8%32.3B+5.5%30.7B+6.8%28.7B+4.0%
-3.27B-198.3%3.33B-67.9%10.4B-40.0%17.3B+12.0%15.4B+17.8%
Additional paid-in capital22.5B+5.4%21.3B+5.7%20.2B+4.9%19.2B+5.1%18.3B+5.3%
Retained earnings-15.5B-96.1%-7.90B-690.0%-1.00B-120.9%4.78B+53.0%3.13B+196.4%
Treasury stock9.15B+11.5%8.20B+25.5%6.53B+42.2%4.59B+46.2%3.14B+38.8%
Accumulated other comprehensive income-1.14B+40.6%-1.93B+16.5%-2.31B-4.8%-2.20B+24.1%-2.90B+7.0%
Non-controlling interest42.0M+7.7%39.0M+5.4%37.0M+12.1%33.0M+17.9%28.0M+33.3%
Total equity incl. non-controlling-3.23B-196.0%3.36B-67.6%10.4B-39.9%17.3B+12.0%15.4B+17.9%
Total liabilities & equity134B-0.9%135B+0.3%135B-2.9%139B-5.3%147B-2.7%
Common shares issued1.84B+0.4%1.83B+0.5%1.82B+0.5%1.81B+0.6%1.80B+0.6%
Shares outstanding (cover)1.77B+0.2%1.77B-0.1%1.77B-0.2%1.77B+0.0%1.77B+0.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
19.0B+1.2%18.8B-17.7%22.8B-8.4%24.9B+9.5%22.8B+29.5%
Depreciation & amortization8.14B-2.9%8.39B-3.6%8.70B+2.7%8.47B-0.6%8.52B+31.7%
Intangible amortization7.38B-3.2%7.62B-4.1%7.95B+3.3%7.69B-0.4%7.72B+33.0%
Share-based compensation955M+4.8%911M+22.0%747M+11.3%671M-3.0%692M-8.1%
Deferred income taxes-492M+66.0%-1.45B+49.8%-2.89B-49.6%-1.93B-115.0%-898M+61.4%
Change in receivables1.49B+819.8%-207M-213.6%-66.0M-104.5%1.46B+10.1%1.32B+42.2%
Change in inventory234M-26.6%319M-23.5%417M-39.2%686M+383.1%142M+255.0%
-6.64B+68.1%-20.8B-936.3%-2.01B-222.5%-623M+73.4%-2.34B+93.8%
Capital expenditure1.21B+24.6%974M+25.4%777M+11.8%695M-11.7%787M-1.4%
Free cash flow17.8B-0.1%17.8B-19.2%22.1B-9.0%24.2B+10.3%22.0B+31.0%
Acquisitions204M-98.8%17.5B0.00-100.0%255M-51.4%525M-98.6%
Sales/maturities of investments76.0M-86.3%555M+909.1%55.0M-96.4%1.53B+1461.2%98.0M-93.6%
Other investing activities29.0M+115.3%-189M-1353.8%-13.0M+98.3%-774M-111.5%-366M+73.6%
-12.7B-144.2%-5.21B+69.7%-17.2B+30.6%-24.8B-30.3%-19.0B-65.5%
Long-term debt issued3.99B-76.5%17.0B0.00-100.0%2.00B+100.0%1.00B-66.7%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased980M-42.6%1.71B-13.4%1.97B+32.6%1.49B+59.2%934M-4.5%
Dividends paid11.7B+5.7%11.0B+4.6%10.5B+4.9%10.0B+8.4%9.26B+20.0%
Other financing activities68.0M+19.3%57.0M+18.8%48.0M+60.0%30.0M+25.0%24.0M+200.0%
FX effect on cash42.0M+164.6%-65.0M-1400.0%5.00M+108.1%-62.0M+36.1%-97.0M-1840.0%
Net change in cash-295M+96.0%-7.29B-301.8%3.61B+762.9%-545M-142.0%1.30B+104.1%
Interest paid3.00B+6.8%2.81B+13.9%2.47B-3.0%2.55B-6.1%2.71B+3.6%
Income taxes paid3.63B-11.6%4.10B-12.8%4.70B+57.3%2.99B-18.1%3.65B+117.9%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap404B+28.8%314B+14.7%274B-4.3%286B+19.3%239B+26.6%
P/E95.6×+30.4%73.3×+74.6%42.0×+97.0%21.3×+2.7%20.7×-49.4%
P/S6.6×+18.6%5.6×+12.2%5.0×+0.4%4.9×+16.0%4.3×+3.2%
P/B—94.3×+317.0%22.6×+26.6%17.9×+15.0%15.5×+7.4%
P/FCF22.7×+28.9%17.6×+59.0%11.1×-15.1%13.0×+19.7%10.9×-3.4%
Earnings yield1.0%-23.3%1.4%-42.7%2.4%-49.2%4.7%-2.7%4.8%+97.6%
FCF yield4.4%-22.4%5.7%-37.1%9.0%+17.8%7.7%-16.5%9.2%+3.5%
Dividend yield2.9%-17.8%3.5%-8.4%3.9%+9.4%3.5%-9.9%3.9%-13.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ABBV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ABBV filings on SEC EDGAR → Not investment advice.